Tag: AnteoTech
AnteoTech inks EuGeni distribution agreement for Greece and Cyprus
Queensland biotechnology company AnteoTech has signed a distribution agreement with Ramma Dental SA for the distribution of its EuGeni Reader and accompanying COVID-19 Antigen...
AnteoTech inks Philippines distribution agreement for EuGeni
Brisbane company AnteoTech has signed a distribution agreement with UC Biosciences Inc. (Unison) for the distribution of the EuGeni Reader platform and Covid-19 Antigen...
AnteoTech signs UK distribution agreement with Apacor Limited
Queensland-based biotechnology company AnteoTech has signed a distribution agreement with Apacor Limited for the distribution of the EuGeni Reader and accompanying COVID-19 Antigen Rapid...
AnteoTech inks first multi-territory EuGeni distribution agreement with Biomed Global
Queensland-based biotechnology company AnteoTech has signed a distribution agreement with Biomed Global and its subsidiaries for the distribution of its EuGeni Reader and accompanying...
Palaszczuk Government launches $1.84 billion jobs fund
Media Release
The Palaszczuk Government has launched a new flagship program, bringing together $1.84 billion in measures designed to turbo-charge job creation in Queensland.
Premier Annastacia...
AnteoTech officially launches 15-minute rapid COVID-19 test
Media Release
Queensland company AnteoTech has officially launched its 15-minute COVID-19 antigen rapid test (ART) platform, EuGeni.
Deputy-Premier and Minister for State Development Steven Miles joined...
AnteoTech’s 15-min rapid Covid-19 test wins European tick of approval
Life science and nano-scale surface chemistry company, AnteoTech, has won a crucial European accreditation for its innovative point-of-care COVID-19 antigen rapid test platform, EuGeni.
AnteoTech...
Brisbane company to accelerate development of rapid COVID-19 test
Media Release
Brisbane company AnteoTech is one step closer to delivering an innovative point-of-care (PoC) rapid COVID-19 test thanks to vital funding from the Palaszczuk...